Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.9900
+0.0235 (2.43%)
Jan 15, 2026, 10:26 AM EST - Market open

Enlivex Therapeutics Market Cap

Enlivex Therapeutics has a market cap or net worth of $235.01 million as of January 15, 2026. Its market cap has increased by 798.09% in one year.

Market Cap
235.01M
Enterprise Value
211.93M
1-Year Change
798.09%
Ranking
Category
Stock Price
$0.99

Market Cap Chart

Since March 26, 2019, Enlivex Therapeutics's market cap has increased from $101.63M to $235.01M, an increase of 131.24%. That is a compound annual growth rate of 13.10%.

History

DateMarket Cap% Change
Jan 14, 2026229.43M37.44%
Dec 31, 2025166.93M548.82%
Dec 31, 202425.73M-48.77%
Dec 29, 202350.22M-30.73%
Dec 30, 202272.50M-36.72%
Dec 31, 2021114.57M-5.58%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Mar 26, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Eli Lilly and Company961.00B
Johnson & Johnson526.55B
AbbVie392.16B
UnitedHealth Group303.42B
AstraZeneca299.25B
Novartis AG278.73B
Merck & Co.275.53B
Novo Nordisk262.20B
Market Cap Rankings